He succeeds Tim Edwards who will step down at the October Board meeting
The BioIndustry Association (BIA) has elected Edward Hodgkin as its new Chairman, effective 30 October. Hodgkin succeeds Tim Edwards, who will formally step down at the October Board meeting after three years as BIA Chairman. Edwards will remain a member of the BIA Board.
Hodgkin has been a non-executive director of the BIA since 2010 and serves as a member of the BIA's Executive Committee. He is a partner with investment company Syncona Partners, a subsidiary of the Wellcome Trust, where his role is to create and lead new life science ventures. Prior to joining Syncona in April 2013, he was CEO of Biotica Technology, a Cambridge therapeutics company, from 2007 to 2012. Trained as a chemist, Hodgkin has served in a variety of scientific, business and management roles in biotech and pharmaceutical companies in the US and UK in a career of more than 20 years.